Skip to main navigation menu Skip to main content Skip to site footer

Original article

Vol. 144 No. 0708 (2014)

Prediction of arrhythmic events by Wedensky modulation in patients with coronary artery disease

  • Andreas W Schoenenberger
  • Olivia Schär
  • Richard Kobza
  • Paul Erne
Cite this as:
Swiss Med Wkly. 2014;144:w13929


PRINCIPLES: Prediction of arrhythmic events (AEs) has gained importance with the availability of implantable cardioverter-defibrillators (ICDs), but is still imprecise. This study evaluated the innovative Wedensky modulation index (WMI) as predictor of AEs.

METHODS: In this prospective cohort, 179 patients with coronary artery disease (CAD) referred for AE risk assessment underwent baseline evaluation including measurement of R-/T-wave WMI (WMIRT) and left ventricular ejection fraction (LVEF). Two endpoints were assessed 3 years after the baseline evaluation: sudden cardiac death or appropriate ICD event (EP1) and any cardiac death or appropriate ICD event (EP2). Associations between baseline predictors (WMIRT and LVEF) and endpoints were evaluated in regression models.

RESULTS: Only three patients were lost to follow-up. EP1 and EP2 occurred in 24 and 27 patients, respectively. WMIRT (odds ratio [OR] per 1 point increase for EP1 20.1, 95% confidence interval [CI] 1.8–221.4, p = 0.014, and for EP2 73.3, 95% CI 6.6–817.7, p <0.001) and LVEF (OR per 1% increase for EP1 0.94, 95% CI 0.90–0.99, p = 0.013, and for EP2 0.93, 95% CI 0.89–0.97, p = 0.002) were significantly associated with both endpoints. In bivariable regression controlled for LVEF, WMIRT was independently associated with EP1 (p = 0.047) and EP2 (p = 0.007). The combination of WMIRT ≥0.60 and LVEF ≤30% resulted in a positive predictive value of 36% for EP1 and 50% for EP2.

CONCLUSIONS: WMIRT is a significant predictor of AEs independent of LVEF and has potential to improve AE risk prediction in CAD patients. However, WMIRT should be evaluated in larger and independent samples before recommendations for clinical routine can be made.


  1. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996;335:1933–40.
  2. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 1999;341:1882–90.
  3. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877–83.
  4. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008;117:e350–408.
  5. Schaer B, Kühne M, Koller MT, Sticherling C, Osswald S. Therapy with an implantable cardioverter defibrillator (ICD) in patients with coronary artery disease and dilated cardiomyopathy: benefits and disadvantages. Swiss Med Wkly. 2009;139:647–53.
  6. Fishman GI, Chugh SS, Dimarco JP, Albert CM, Anderson ME, Bonow RO, et al. Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. Circulation. 2010;122:2335–48.
  7. Bigger JT Jr, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation. 1984;69:250–8.
  8. Gomes JA, Winters SL, Stewart D, Horowitz S, Milner M, Barreca P. A new noninvasive index to predict sustained ventricular tachycardia and sudden death in the first year after myocardial infarction: based on signal-averaged electrocardiogram, radionuclide ejection fraction and Holter monitoring. J Am Coll Cardiol. 1987;10:349–57.
  9. Schoenenberger AW, Kobza R, Jamshidi P, Zuber M, Abbate A, Stuck AE, et al. Sudden cardiac death in patients with silent myocardial ischemia after myocardial infarction (from the Swiss Interventional Study on Silent Ischemia Type II [SWISSI II]). Am J Cardiol. 2009;104:158–63.
  10. Schoenenberger AW, Erne P, Ammann S, Gillmann G, Kobza R, Stuck AE. Prediction of arrhythmic events after myocardial infarction based on signal-averaged electrocardiogram and ejection fraction. Pacing Clin Electrophysiol. 2008;31:221–8.
  11. Altmann DR, Mutschelknauss M, Ehl N, Koller M, Schaer B, Jörg L, et al. Prevalence of severely impaired left ventricular ejection fraction after reperfused ST-elevation myocardial infarction. Swiss Med Wkly. 2013;143:w13869.
  12. Berdajs D, Marinakis S, Kessler U, Muradbegovic M, Ferrari E, von Segesser LK. Impaired left ventricular function as a predictive factor for mid-term survival in octogenarians after primary coronary artery bypass surgery. Swiss Med Wkly. 2012;142:w13704.
  13. Wedensky NE. Über die Beziehung zwischen Reizung und Erregung im Tetanus. Ber Akad Wiss (St. Petersburg) 1886;54:96. German.
  14. Castellanos A, Jr, Lemberg L, Johnson D, Berkovits BV. The Wedensky effect in the human heart. Br Heart J. 1966;28:276–83.
  15. Amlie JP, Hoium H, Mathisen P, Malik M, Brady PA. The Wedensky test predicts malignant ventricular arrhythmias after myocardial infarction. Scand Cardiovasc J. 2013;47:256–62.
  16. Hnatkova K, Ryan SJ, Hoium HH, Malik M. Noninvasive assessment of Wedensky modulated signal-averaged electrocardiograms. Pacing Clin Electrophysiol. 2000;23:1977–80.
  17. Hnatkova K, Ryan SJ, Bathen J, Hoium HH, Malik M. Non-invasive Wedensky modulation within the QRS complex. Med Biol Eng Comput. 2002;40:234–40.
  18. Elgarhi N, Kreuz J, Balta O, Nickenig G, Hoium H, Lewalter T, et al. Significance of Wedensky Modulation testing in the evaluation of non-invasive risk stratification for ventricular tachyarrhythmia in patients with coronary artery disease and implantable cardioverter-defibrillator. Heart. 2008;94:e16.
  19. Goupillaud P, Grossman A, Morlet J. Cycle-Octave and Related Transforms in Seismic Signal Analysis. Geoexploration. 1984;23:85–102.
  20. Morlet D, Peyrin F, Desseigne P, Touboul P, Rubel P. Wavelet analysis of high-resolution signal-averaged ECGs in postinfarction patients. J Electrocardiol. 1993;26:311–20.
  21. Hinkle LE Jr, Thaler HT. Clinical classification of cardiac deaths. Circulation. 1982;65:457–64.
  22. Pregibon, D. Logistic regression diagnostics. Ann Stat. 1981:9:705–24.
  23. Lee ET, Wang JW. Statistical methods for survival data analysis, 3rd ed. New York, John Wiley & Sons, 2003.
  24. Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007;165:710–8.

Most read articles by the same author(s)

1 2 > >>